The challenging management of borderline ovarian tumors (BOTs) in women of childbearing age

Borderline ovarian tumors (BOTs) account for approximately 15% of all epithelial ovarian cancers. In 80% of cases the diagnosis of BOTs is done at stage I and more than a third of BOTs occurs in women younger than 40 years of age wishing to preserve their childbearing potential; the issue of conserv...

Full description

Bibliographic Details
Main Authors: Luigi Della Corte, Antonio Mercorio, Paolo Serafino, Francesco Viciglione, Mario Palumbo, Maria Chiara De Angelis, Maria Borgo, Cira Buonfantino, Marina Tesorone, Giuseppe Bifulco, Pierluigi Giampaolino
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-08-01
Series:Frontiers in Surgery
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fsurg.2022.973034/full
_version_ 1828151227209220096
author Luigi Della Corte
Antonio Mercorio
Paolo Serafino
Francesco Viciglione
Mario Palumbo
Maria Chiara De Angelis
Maria Borgo
Cira Buonfantino
Marina Tesorone
Giuseppe Bifulco
Pierluigi Giampaolino
author_facet Luigi Della Corte
Antonio Mercorio
Paolo Serafino
Francesco Viciglione
Mario Palumbo
Maria Chiara De Angelis
Maria Borgo
Cira Buonfantino
Marina Tesorone
Giuseppe Bifulco
Pierluigi Giampaolino
author_sort Luigi Della Corte
collection DOAJ
description Borderline ovarian tumors (BOTs) account for approximately 15% of all epithelial ovarian cancers. In 80% of cases the diagnosis of BOTs is done at stage I and more than a third of BOTs occurs in women younger than 40 years of age wishing to preserve their childbearing potential; the issue of conservative surgical management (fertility-sparing treatment) is thus becoming of paramount importance. At early stages, the modalities of conservative treatment could range from mono-lateral cystectomy to bilateral salpingo-oophorectomy. Although cystectomy is the preferred method to promote fertility it can lead to an elevated risk of recurrence; therefore, an appropriate counseling about the risk of relapse is mandatory before opting for this treatment. Nevertheless, relapses are often benign and can be treated by repeated conservative surgery. Besides the stage of the disease, histological subtype is another essential factor when considering the proper procedure: as most mucinous BOTs (mBOTs) are more commonly unilateral, the risk of an invasive recurrence seems to be higher, compared to serous histotype, therefore unilateral salpingo-oophorectomy is recommended. In the appraisal of current literature, this review aims to gain better insight on the current recommendations to identify the right balance between an accurate staging and an optimal fertility outcome.
first_indexed 2024-04-11T21:54:47Z
format Article
id doaj.art-437a8be6126f40c4a2c1137c4a1f00e6
institution Directory Open Access Journal
issn 2296-875X
language English
last_indexed 2024-04-11T21:54:47Z
publishDate 2022-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Surgery
spelling doaj.art-437a8be6126f40c4a2c1137c4a1f00e62022-12-22T04:01:09ZengFrontiers Media S.A.Frontiers in Surgery2296-875X2022-08-01910.3389/fsurg.2022.973034973034The challenging management of borderline ovarian tumors (BOTs) in women of childbearing ageLuigi Della Corte0Antonio Mercorio1Paolo Serafino2Francesco Viciglione3Mario Palumbo4Maria Chiara De Angelis5Maria Borgo6Cira Buonfantino7Marina Tesorone8Giuseppe Bifulco9Pierluigi Giampaolino10Department of Neuroscience, Reproductive Sciences and Dentistry, School of Medicine, University of Naples Federico II, Naples, ItalyDepartment of Neuroscience, Reproductive Sciences and Dentistry, School of Medicine, University of Naples Federico II, Naples, ItalyDepartment of Neuroscience, Reproductive Sciences and Dentistry, School of Medicine, University of Naples Federico II, Naples, ItalyDepartment of Neuroscience, Reproductive Sciences and Dentistry, School of Medicine, University of Naples Federico II, Naples, ItalyDepartment of Neuroscience, Reproductive Sciences and Dentistry, School of Medicine, University of Naples Federico II, Naples, ItalyDepartment of Public Health, University of Naples Federico II, Naples, ItalyDepartment of Public Health, University of Naples Federico II, Naples, ItalyDepartment of Public Health, University of Naples Federico II, Naples, ItalyDepartment of Child and Adolescent Health, U.O.C Protection of Women's- ASL Napoli 1, Naples, ItalyDepartment of Neuroscience, Reproductive Sciences and Dentistry, School of Medicine, University of Naples Federico II, Naples, ItalyDepartment of Public Health, University of Naples Federico II, Naples, ItalyBorderline ovarian tumors (BOTs) account for approximately 15% of all epithelial ovarian cancers. In 80% of cases the diagnosis of BOTs is done at stage I and more than a third of BOTs occurs in women younger than 40 years of age wishing to preserve their childbearing potential; the issue of conservative surgical management (fertility-sparing treatment) is thus becoming of paramount importance. At early stages, the modalities of conservative treatment could range from mono-lateral cystectomy to bilateral salpingo-oophorectomy. Although cystectomy is the preferred method to promote fertility it can lead to an elevated risk of recurrence; therefore, an appropriate counseling about the risk of relapse is mandatory before opting for this treatment. Nevertheless, relapses are often benign and can be treated by repeated conservative surgery. Besides the stage of the disease, histological subtype is another essential factor when considering the proper procedure: as most mucinous BOTs (mBOTs) are more commonly unilateral, the risk of an invasive recurrence seems to be higher, compared to serous histotype, therefore unilateral salpingo-oophorectomy is recommended. In the appraisal of current literature, this review aims to gain better insight on the current recommendations to identify the right balance between an accurate staging and an optimal fertility outcome.https://www.frontiersin.org/articles/10.3389/fsurg.2022.973034/fullbordeline ovarian tumorconservative surgeryovaryfertilityrecurrencesurvival
spellingShingle Luigi Della Corte
Antonio Mercorio
Paolo Serafino
Francesco Viciglione
Mario Palumbo
Maria Chiara De Angelis
Maria Borgo
Cira Buonfantino
Marina Tesorone
Giuseppe Bifulco
Pierluigi Giampaolino
The challenging management of borderline ovarian tumors (BOTs) in women of childbearing age
Frontiers in Surgery
bordeline ovarian tumor
conservative surgery
ovary
fertility
recurrence
survival
title The challenging management of borderline ovarian tumors (BOTs) in women of childbearing age
title_full The challenging management of borderline ovarian tumors (BOTs) in women of childbearing age
title_fullStr The challenging management of borderline ovarian tumors (BOTs) in women of childbearing age
title_full_unstemmed The challenging management of borderline ovarian tumors (BOTs) in women of childbearing age
title_short The challenging management of borderline ovarian tumors (BOTs) in women of childbearing age
title_sort challenging management of borderline ovarian tumors bots in women of childbearing age
topic bordeline ovarian tumor
conservative surgery
ovary
fertility
recurrence
survival
url https://www.frontiersin.org/articles/10.3389/fsurg.2022.973034/full
work_keys_str_mv AT luigidellacorte thechallengingmanagementofborderlineovariantumorsbotsinwomenofchildbearingage
AT antoniomercorio thechallengingmanagementofborderlineovariantumorsbotsinwomenofchildbearingage
AT paoloserafino thechallengingmanagementofborderlineovariantumorsbotsinwomenofchildbearingage
AT francescoviciglione thechallengingmanagementofborderlineovariantumorsbotsinwomenofchildbearingage
AT mariopalumbo thechallengingmanagementofborderlineovariantumorsbotsinwomenofchildbearingage
AT mariachiaradeangelis thechallengingmanagementofborderlineovariantumorsbotsinwomenofchildbearingage
AT mariaborgo thechallengingmanagementofborderlineovariantumorsbotsinwomenofchildbearingage
AT cirabuonfantino thechallengingmanagementofborderlineovariantumorsbotsinwomenofchildbearingage
AT marinatesorone thechallengingmanagementofborderlineovariantumorsbotsinwomenofchildbearingage
AT giuseppebifulco thechallengingmanagementofborderlineovariantumorsbotsinwomenofchildbearingage
AT pierluigigiampaolino thechallengingmanagementofborderlineovariantumorsbotsinwomenofchildbearingage
AT luigidellacorte challengingmanagementofborderlineovariantumorsbotsinwomenofchildbearingage
AT antoniomercorio challengingmanagementofborderlineovariantumorsbotsinwomenofchildbearingage
AT paoloserafino challengingmanagementofborderlineovariantumorsbotsinwomenofchildbearingage
AT francescoviciglione challengingmanagementofborderlineovariantumorsbotsinwomenofchildbearingage
AT mariopalumbo challengingmanagementofborderlineovariantumorsbotsinwomenofchildbearingage
AT mariachiaradeangelis challengingmanagementofborderlineovariantumorsbotsinwomenofchildbearingage
AT mariaborgo challengingmanagementofborderlineovariantumorsbotsinwomenofchildbearingage
AT cirabuonfantino challengingmanagementofborderlineovariantumorsbotsinwomenofchildbearingage
AT marinatesorone challengingmanagementofborderlineovariantumorsbotsinwomenofchildbearingage
AT giuseppebifulco challengingmanagementofborderlineovariantumorsbotsinwomenofchildbearingage
AT pierluigigiampaolino challengingmanagementofborderlineovariantumorsbotsinwomenofchildbearingage